Reaction
Leukaemic Infiltration Extramedullary reporting signals
As of the last recalculation, Leukaemic Infiltration Extramedullary appears in 245 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 6,147.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Blinatumomab | 185 | 6,147.7 | 6,259.4 |
| Fludarabine Phosphate | 20 | 47.0 | 47.0 |
| Azacitidine For | 7 | 33.6 | 33.6 |
| Azacitidine | 11 | 32.9 | 32.9 |
| Dasatinib | 10 | 23.8 | 23.8 |